Latest News & Updates
Other trending news you may like to read
Regeneron’s Lynozyfic Delivers Rapid, Deep Responses In Newly Diagnosed Multiple Myeloma; Phase 1/2 LINKER-MM4 Data Highlight Strong Efficacy And Manageable Safety
Regeneron presents Phase 1/2 data showing Lynozyfic delivers rapid, deep responses in newly diagnosed multiple myeloma at the ASH Annual Meeting.
Vaibhavi M.
Sandoz Strengthens Biosimilar Leadership with Acquisition Of Just-Evotec Biologics EU SAS; Secures Toulouse Site And Continuous Manufacturing Tech To Boost Biosimilar Scale
Sandoz completes acquisition of Evotec’s Toulouse biologics site, boosting continuous manufacturing capabilities and strengthening its global biosimilars strategy.
Vaibhavi M.
Praxis Advances Essential Tremor Program After Successful FDA Pre-NDA Meeting And Expects Early 2026 Submission
Praxis secures FDA alignment in its pre-NDA meeting and prepares a 2026 NDA submission for ulixacaltamide, a potential new therapy for essential tremor.
Vaibhavi M.
Merck’s New Animal Health’s Isoxazoline Parasiticide EXZOLT CATTLE-CA1 For Screwworm And Tick Control Set For U.S. Launch Following FDA Conditional Clearance
FDA grants conditional approval to Merck’s EXZOLT CATTLE-CA1, a new fluralaner treatment for screwworm and cattle fever ticks in beef cattle.
Vaibhavi M.
